221 related articles for article (PubMed ID: 15046543)
1. In the treatment of depression, does selectivity of action matter?
J Clin Psychiatry; 2004; 65 Suppl 4():60-2. PubMed ID: 15046543
[No Abstract] [Full Text] [Related]
2. Norepinephrine involvement in antidepressant action.
Frazer A
J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
[TBL] [Abstract][Full Text] [Related]
3. Does depression hurt?
Stahl SM
J Clin Psychiatry; 2002 Apr; 63(4):273-4. PubMed ID: 12000200
[TBL] [Abstract][Full Text] [Related]
4. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.
Lucki I; O'Leary OF
J Clin Psychiatry; 2004; 65 Suppl 4():11-24. PubMed ID: 15046537
[TBL] [Abstract][Full Text] [Related]
6. The role of norepinephrine in the treatment of depression.
J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
[No Abstract] [Full Text] [Related]
7. Depression: the relevance of the time factor.
Pinder RM
J Clin Psychiatry; 2001; 62 Suppl 15():5-7. PubMed ID: 11444764
[No Abstract] [Full Text] [Related]
8. Psychobiology and psychopharmacotherapy of unipolar major depression: a review.
O'Toole SM; Johnson DA
Arch Psychiatr Nurs; 1997 Dec; 11(6):304-13. PubMed ID: 9419922
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of antidepressants: selectivity or multiplicity?
Westenberg HG
J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic mechanisms and the new antidepressants.
Stahl SM
Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
[No Abstract] [Full Text] [Related]
11. Can recovery from depression be achieved?
Shelton RC; Tomarken AJ
Psychiatr Serv; 2001 Nov; 52(11):1469-78. PubMed ID: 11684742
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological principles of antidepressant efficacy.
Schatzberg AF
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
[TBL] [Abstract][Full Text] [Related]
13. Considerations in choosing an antidepressant.
Kingsbury SJ; Simpson GM
Psychiatr Serv; 2001 Nov; 52(11):1435-6. PubMed ID: 11684736
[No Abstract] [Full Text] [Related]
14. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of microdialysis findings.
Deakin JF; Graeff FG; Guimaraes FS
Trends Pharmacol Sci; 1993 Jul; 14(7):263. PubMed ID: 8129813
[No Abstract] [Full Text] [Related]
16. Introduction: the dual-action debate: does pharmacology matter?
Thase ME
J Clin Psychiatry; 2004; 65 Suppl 17():3-4. PubMed ID: 15600375
[No Abstract] [Full Text] [Related]
17. Differences in mechanism of action between current and future antidepressants.
Stahl SM; Grady MM
J Clin Psychiatry; 2003; 64 Suppl 13():13-7. PubMed ID: 14552651
[TBL] [Abstract][Full Text] [Related]
18. Monoamine dysfunction and the pathophysiology and treatment of depression.
Charney DS
J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
[TBL] [Abstract][Full Text] [Related]
19. Prescribing update: why choose duloxetine for depression?
Tobin ML
Issues Ment Health Nurs; 2007 Jan; 28(1):117-20. PubMed ID: 17130011
[No Abstract] [Full Text] [Related]
20. Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond.
Owens MJ
J Clin Psychiatry; 2004; 65 Suppl 4():5-10. PubMed ID: 15046536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
